BIO International Convention 2025

Date: June 16-19, 2025

Venue: Boston Convention & Exhibition Center

Frequency: Annual

Organizor: Biotechnology Innovation Organization

Event Introduction:

Founded in 1993, BIO International Convention (BIO) is the annual meeting of the U.S.-based Global Biotechnology Innovation Organization (GBIO); the world's largest, most professional, and most influential biotechnology event, representing the entire biotechnology ecosystem.BIO is designed to help grow the global biotechnology industry. By supporting biotechnology programs and initiatives, profits from the BIO International Congress are returned to the biotechnology industry. 20,000 industry leaders from around the world attend the show in 2024.

The show does not aim at trade transactions, but focuses more on the mode of both exhibition and conference; providing a platform for enterprises, science and technology parks and R&D institutions to publicize and display; and providing a comprehensive platform for exhibitors and participants to exchange and disseminate information, technological cooperation and transactions, and risk investment and financing by organizing professional forums, conferences, exchanges, and docking and negotiation activities.

Whether you work at a public pharmaceutical company, biotech startup, academia, non-profits, and government or are a researcher, business development professional or investor, BIO is where you'll make valuable connections and build relationships. Our proprietary BIO One-on-One Partnering™ match-making platform—included in the Premier Access registration package—allows you to find potential partners, schedule and accept meetings.

Facts: 

Bio 2024 in San Diego was a huge success thanks to a record number of partner meetings and nearly 20,000 registrants: 19,608 registrants, 61,508 partner meetings, 1,500+ exhibitors, visitors from all 50 states in the U.S., as well as international visitors and exhibitors from 68 countries, and 150 official U.S. and international organizations.

Why Attend BIO?

1. Catering to Emerging Biotech Companies: BIO is committed to catering to the needs of small and mid-sized companies because most of them have yet to have their major products approved and marketed. Whether it is advocating for tax policies that support innovation or encouraging an economic and policy environment that facilitates biotechnology investment, we focus on the key issues affecting small companies and develop programs to facilitate their growth.

2. Advocating for Healthy Biotechnology Innovation: BIO promotes biomedical innovation by developing and advocating for public policies that represent the best interests of members concerned about human health. We break down the barriers that impede innovation in the U.S. by reducing bureaucratic barriers to life-saving technologies. Priorities include matters affecting the healthcare-related regulatory and reimbursement environment, pandemic and biodefense preparedness, publicly funded scientific research, and personalized medicine.

3. Breakthrough agriculture and environmental optimization: BIO is committed to supporting biobased breakthroughs at all stages of development and for technology developers of all types and sizes. From public education campaigns to promoting regulations that keep pace with innovation, we face policy challenges and activism that can threaten food and farm innovation, biobased manufacturing, and green energy breakthroughs.:

Products: 
Biotechnology and products, biopharmaceutical R&D results, construction of bioparks and industrial bases, application of biotechnology in healthcare, food, agriculture, energy, environmental protection, etc., as well as marketing of biotechnology products in the international market and academic promotion, protection of intellectual property rights, clinical research and clinical trials, investment and financing, and technology transfer.

Focus Areas: 

Artificial Intelligence (AI) & Digital Health, Biomanufacturing, Brain Health, Business Development & Finance, Cell & Gene Therapy & Genome Editing, Diagnostics & Personalized Medicine, Diversity, Equity & Inclusion, Emerging Opportunities in Global Markets, Environmental Sustainability, Infectious Diseases & Vaccines, Intellectual Property Rights, Prospects for Drug Legitimacy & Commercialization, Next-Generation Biotherapeutic Drugs, Oncology, Orphan & Rare Diseases, Patient Advocacy, Regulatory and Clinical Innovation, Medical Translational Research, Value, Patient Access (Payment Related) and Reimbursement, etc.

Contact:  Mrs. Sherry Yang

Tel: 86-21-36050835      Fax: 86-21-36050835

Mobile: 86-18301987747

Email: sherryyang@pe-exhibition.com

Address: Room 601&611 607, Carnival Building, No. 210, 1st Dahua Road, Baoshan District, Shanghai